A jump in the number of people with serious illness caused by group A Streptococcus — also referred to as Strep A — has made headlines recently. There has also been a higher than usual number of deaths from group A Streptococcus infections, including in children, leaving people with questions about why and how these infections are spreading, and what symptoms to be aware of.
Shortly after the number of COVID-19 infections diminished worldwide, a considerable increase in patients diagnosed with diseases caused by group A Streptococcus began in different parts of the world.
Why did these bacteria suddenly become a global concern? To answer this question, it is essential to know some specifics of this disease to gain a better understanding of its cause. Group A Streptococcus exclusively affects humans, and its spread occurs via airborne droplets as well as person-to-person contact.
Among the different illnesses caused by this organism are respiratory tract infections such as tonsillitis and pharyngitis (symptoms of classic strep throat), as well as superficial skin infections and skin infections known as pyoderma.
However, Group A Streptococcus can sometimes develop into invasive infections that put patients’ lives at risk, such as necrotizing fasciitis, septicemia (blood poisoning), and streptococcal toxic shock syndrome.
A new variant of group A Streptococcus called M1UK was first reported in the United Kingdom, where it has been linked to an increase in scarlet fever cases as well as an increase in invasive infections.
What could account for the current spike in cases?
Up to approximately 10 per cent of school-aged children will commonly carry these bacteria in their throats and upper respiratory tract without having any symptoms, and over time will develop some level of immunity to it.
It is likely that during the COVID pandemic, children were at home and not being exposed to the bacteria as much as before and so their immune systems are probably not as good at fighting these infections. Without this exposure, some children are likely to be more susceptible to infection.
The spread of the new M1UK strain is also probably why there is an increased number of cases, although this is something that is currently being studied.
Should people be concerned about these rising numbers? Generally, Canadians should not be overly concerned because serious infections with group A Streptococcus are still quite rare.
However, people should also not ignore strep throat, and should get treatment from a doctor and be wary of symptoms that might suggest an invasive infection.
Strep throat requires treatment, as untreated strep throat can lead to other problems including invasive infections.
How to protect yourself and when to seek medical care
Because group A Streptococcus are common and many carriers are asymptomatic, it can be difficult to avoid exposure. Practising good hand hygiene, covering coughs and sneezes, staying home when you’re sick and not sending children to school if they have a very sore throat are all good measures.
If you believe you have a strep infection such as strep throat with painful swallowing, fever, swollen tonsils or a rash, talk to a family physician to determine if the infection is caused by group A Streptococcus. A rapid strep test can be done with a throat swab. If the test is positive, antibiotics can be prescribed.
Invasive group A strep infections are very dangerous and are a medical emergency, although initial symptoms may not be obvious. These could include fever, chills, flu-like symptoms and nausea or vomiting, but in particular red and warm skin infections that may be very painful and spread rapidly.
There is strong evidence that prior viral infections such as chickenpox can predispose people for developing invasive group A Streptococcus. Children with chickenpox should be watched carefully for symptoms of invasive group A Strep.
Currently, there is no vaccine against group A Streptococcus, although there is a vaccine for chickenpox. Multiple research teams around the world, including our own lab, are working towards developing an effective vaccine against this human pathogen.
professor of microbiology and immunology at the University of Western Ontario; post-doctoral associate, department of microbiology and immunology at Western. This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts.